By Sabela OjeaCara Therapeutics on Monday reported a narrower loss in its latest quarter. Shares of the commercial-stage biopharmaceutical company climbed 8.4% o $4.50 in after-hours trading. Coherus BioSciences said it had commenced an underwritten public offering of $50 million of its common stock. Shares of the biopharmaceutical company fell 7.8% to $4.51 in after-hours trading.

Source: Wall Street Journal May 16, 2023 09:45 UTC